Raras
Buscar doenças, sintomas, genes...
Talassemia beta major
ORPHA:231214CID-10 · D56.1CID-11 · 3A50.2PCDT · SUSDOENÇA RARA

A beta-talassemia (BT) major é uma forma grave de BT de início precoce, caracterizada por anemia grave que requer transfusões regulares de glóbulos vermelhos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A beta-talassemia (BT) major é uma forma grave de BT de início precoce, caracterizada por anemia grave que requer transfusões regulares de glóbulos vermelhos.

Pesquisas ativas
31 ensaios
347 total registrados no ClinicalTrials.gov
Publicações científicas
2.549 artigos
Último publicado: 2026
Medicamentos
5 registrados
AZACITIDINE, AMLODIPINE, RUXOLITINIB

Tem tratamento?

5 medicamentos registrados
Ver detalhes, fases e interações →
AZACITIDINEAMLODIPINERUXOLITINIBSOTATERCEPTBETIBEGLOGENE AUTOTEMCEL

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponível1 medicamentos CEAFCID-10: D56.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (1)
0202010317
Eletroforese de hemoglobinaslab_test
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
8 sintomas
🫃
Digestivo
7 sintomas
❤️
Coração
3 sintomas
🦴
Ossos e articulações
3 sintomas
🩸
Sangue
3 sintomas
😀
Face
3 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Volume corpuscular médio diminuído
Muito frequente (99-80%)
90%prev.
Persistência de hemoglobina F
Muito frequente (99-80%)
90%prev.
Anemia por produção inadequada
Muito frequente (99-80%)
90%prev.
Anisopoiquilocitose
Muito frequente (99-80%)
90%prev.
Anemia microcítica hipocrômica
Muito frequente (99-80%)
90%prev.
Hemoglobina A reduzida
Muito frequente (99-80%)
50sintomas
Muito frequente (8)
Frequente (16)
Ocasional (23)
Muito raro (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 50 características clínicas mais associadas, ordenadas por frequência.

Volume corpuscular médio diminuídoDecreased mean corpuscular volume
Muito frequente (99-80%)90%
Persistência de hemoglobina FPersistence of hemoglobin F
Muito frequente (99-80%)90%
Anemia por produção inadequadaAnemia of inadequate production
Muito frequente (99-80%)90%
AnisopoiquilocitoseAnisopoikilocytosis
Muito frequente (99-80%)90%
Anemia microcítica hipocrômicaHypochromic microcytic anemia
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.549PubMed
Últimos 10 anos200publicações
Pico2025110 papers
Linha do tempo
2026Hoje · 2026🧪 1978Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

HBBHemoglobin subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in oxygen transport from the lung to the various peripheral tissues LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure Functions as an endogenous inhibitor of enkephalin-degrading enzymes such as DPP3, and as a selective antagonist of the P2RX3 receptor which is involved in pain signaling, these properties implicate it as a regulator of pain and inflammation

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Chaperone Mediated Autophagy
MECANISMO DE DOENÇA

Heinz body anemias

Form of non-spherocytic hemolytic anemia of Dacie type 1. After splenectomy, which has little benefit, basophilic inclusions called Heinz bodies are demonstrable in the erythrocytes. Before splenectomy, diffuse or punctate basophilia may be evident. Most of these cases are probably instances of hemoglobinopathy. The hemoglobin demonstrates heat lability. Heinz bodies are observed also with the Ivemark syndrome (asplenia with cardiovascular anomalies) and with glutathione peroxidase deficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
267405.0 TPM
Baço
3152.1 TPM
Pulmão
1300.8 TPM
Adipose Visceral Omentum
607.7 TPM
Rim - Medula
605.7 TPM
OUTRAS DOENÇAS (21)
sickle cell diseasebeta-thalassemia HBB/LCRBdominant beta-thalassemiahemoglobin M disease
HGNC:4827UniProt:P68871

Medicamentos e terapias

AZACITIDINEPhase 2

Mecanismo: DNA (cytosine-5)-methyltransferase 3A inhibitor

AMLODIPINEPhase 2

Mecanismo: Voltage-gated L-type calcium channel blocker

RUXOLITINIBPhase 2

Mecanismo: Tyrosine-protein kinase JAK1 inhibitor

SOTATERCEPTPhase 2

Mecanismo: Inhibin beta A chain inhibitor

BETIBEGLOGENE AUTOTEMCELPhase 1

Mecanismo: Hemoglobin beta chain exogenous gene

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

615 variantes patogênicas registradas no ClinVar.

🧬 HBB: NM_000518.5(HBB):c.127T>A (p.Phe43Ile) ()
🧬 HBB: NM_000518.5(HBB):c.-48A>T ()
🧬 HBB: NM_000518.5(HBB):c.325A>C (p.Asn109His) ()
🧬 HBB: NM_000518.5(HBB):c.331del (p.Leu111fs) ()
🧬 HBB: NM_000518.5(HBB):c.84_90del (p.Leu29fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 7 variantes classificadas pelo ClinVar.

7
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
HBB: NC_000011.10:g.5225256_5225875delinsTCTACTT [Pathogenic]
HBB: NM_000518.5(HBB):c.93-1G>C [Pathogenic]
HBB: NM_000518.5(HBB):c.316-2A>C [Pathogenic]
HBB: NM_000518.5(HBB):c.316-197C>T [Pathogenic]
HBB: NM_000518.5(HBB):c.93-21G>A [Pathogenic/Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
2Fase 211
1Fase 14
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 5 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Talassemia beta major

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

20 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT03937817 · Collection of Human Biospecimens for Basic and Clinical Rese…Recrutando
NCT06364774 · ALS20-101 Lentiviral Gene Therapy for Beta ThalassemiaRecrutando
PHASE1, PHASE2
NCT05736419 · A Study of Immune Suppression Treatment for People With Sick…Recrutando
PHASE2
NCT05477563 · Evaluation of Efficacy and Safety of a Single Dose of CTX001…Recrutando
PHASE3
NCT06421636 · A Study to Test the Safety, Tolerability, and Efficacy of an…Recrutando
PHASE2
NCT05508932 · Atrial Fibrillation in Beta-ThalassemiaRecrutando
NCT07215975 · A Real-World Study to Evaluate Luspatercept in Adults With T…Recrutando
NCT06931912 · Growth Evaluation, Health Promotion, and Clinical Management…Recrutando
NA
NCT05904093 · Study to Evaluate the Safety and Tolerability of Escalating …Recrutando
PHASE1
NCT06647979 · Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sev…Recrutando
PHASE1
NCT04143724 · Study of Safety & PK of Luspatercept (ACE-536) in Pediatric …Recrutando
PHASE2
NCT07292259 · Combination of Thalidomide and Hydroxyuria in Transfusion De…Recrutando
PHASE2
NCT06308159 · An Open-label Study of a Gene Therapy Product (Vebeglogene A…Recrutando
PHASE1, PHASE2
NCT04064060 · A Study to Evaluate Long-term Safety in Participants Who Hav…Recrutando
PHASE3
NCT04208529 · A Long-term Follow-up Study in Participants Who Received CTX…Por convite
PHASE3
NCT06328764 · CS-101 in Patients With β-thalassemiaPor convite
EARLY_PHASE1
NCT06717932 · A Follow-up Study to Evaluate the Long-term Safety and Effic…Por convite
NCT06685536 · A Long-term Follow-up Study in Participants Who Received CS-…Por convite
NCT05577312 · Safety and Efficacy Evaluation of BRL-101 in Subjects With T…Por convite
PHASE1, PHASE2
NCT07055503 · Use of the Hemanext One® Hypoxic Red Blood Cell Storage Syst…Por convite

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.204 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.204

#1

Antioxidant Effects of CoQ10 in Transfusion-Dependent β-Thalassemia Major Patients: Implications for Ferroptosis-Related Pathways.

Journal of blood medicine2026

The role of oxidative stress and ferroptosis in the pathogenesis of thalassemia major have been established and have been shown to cause tissue damage and disease progression. The lipophilic antioxidant coenzyme Q10 (CoQ10) can protect against tissue damage by restoring antioxidant enzyme function and decreasing oxidative damage. This study evaluated the effect of CoQ10 supplementation on biomarkers of ferroptosis in patients with thalassemia major. In this single-arm pre-post study, patients with confirmed thalassemia major (48) received oral CoQ10 (100 mg/day) for 8 weeks. Peripheral blood samples were collected before and after the study period for assays to measure antioxidant enzyme activity: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). Statistical analyses were conducted using paired T-test and Wilcoxon. CoQ10 supplementation significantly increased SOD and GPx activity compared to baseline, (p < 0.05). No significant change was seen in CAT activity. No statistically significant differences were observed in hematological parameters and ferritin level after using CoQ10. CoQ10 supplementation appears to exert protective effects against ferroptosis in patients with thalassemia major, primarily by enhancing antioxidant defenses. Our study findings support the hypothesis that CoQ10 may represent a potential adjunctive therapy in mitigating oxidative stress and ferroptotic damage.

#2

Clinical integration of red cell genotyping in children with β-thalassemia major: a prospective observational study.

Blood global hematology2026 Mar

Blood group serology frequently fails in chronically transfused patients. Discrepancies between phenotype and genotype were reported for 51% of patients with β-thalassemia in 2013; however, red cell genotyping has not become clinical routine in Turkey. We evaluated the current situation by reviewing all patients with β-thalassemia major at the main pediatric hematology outpatient clinic in Ankara for 9 months. A commercial kit was used for red cell genotyping, along with nucleotide sequencing in 51 patients. A total of 1734 antigens were determined by genotyping and were compared with the phenotype on record for 306 antigens of the Rh and Kell systems. We found up to 3 discrepancies in reported phenotype vs the genotype in 25 patients (49%). Notably, the discrepancy rate has remained unchanged over the past 10 years. The 3 patients with alloantibodies received significantly more transfusions than those without (90 ± 9 vs 73 ± 19; P = .015). Patients with discrepancies trended toward hepatic iron overload (84% vs 58%; P = .071). Other clinical parameters, namely transfusion frequency, growth, ferritin levels, and liver and cardiac functions, were comparable between patients with and those without discrepancies. By assessing red cell genotyping for its possible clinical benefit, we immediately improved transfusion practice in half of the children with β-thalassemia major. The implementation of red cell genotyping, a high-throughput method with a rapid turnaround time, will enhance antigen matching. Our real-world data may serve as evidence in the decision processes for the implementation of genotyping in countries in which red cell genotyping is not yet common practice.

#3

Altered cerebral morphometry and individual-based morphological brain network in children with beta-thalassaemia major.

Neuroscience2026 Mar 27

Beta-thalassemia major (TM) is a severe genetic blood disorder that frequently leads to cognitive impairments in pediatric patients, yet its neurological impact remains insufficiently explored. This study investigates alterations in cerebral gray matter morphology and brain network topology in children with TM and their associations with cognitive performance. High-resolution brain MRI data were processed using FreeSurfer to extract cortical morphological features, from which individual-based Morphological Brain Networks (MBNs) were constructed based on vertex-wise similarity across gray matter regions. A cohort of 27 children with TM and 40 age-matched healthy controls underwent structural network analysis, standardized cognitive assessments, and comprehensive blood testing, including evaluations of hemoglobin and iron concentrations. Results revealed marked structural disruptions in the motor and temporal cortices of TM patients. Network-level analysis further identified topological abnormalities within fronto-parietal regions, suggesting altered structural connectivity patterns that may underlie observed cognitive deficits. Notably, iron overload was significantly correlated with both regional brain changes and impaired network organization, indicating a plausible mechanistic link between systemic iron dysregulation and neural dysfunction. These findings underscore the neurological vulnerability of children with TM and illuminate the structural basis of their cognitive challenges. The study highlights the need to integrate neuroimaging biomarkers with clinical hematological profiles to better understand TM's effects on brain development. Future work should aim to expand these findings through longitudinal designs and larger samples to inform early neurocognitive interventions and optimize treatment strategies for this vulnerable population.

#4

Effect of Closed Kinetic Chain Exercise Via Telerehabilitation on Muscle Strength, Balance, Fatigue and Hemoglobin Levels in Beta Thalassemia Major Children: A Randomized Controlled Trial.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2026 Jan

Children with thalassemia often suffer from complications such as muscle weakness, bone fragility, fatigue and reduced physical endurance. As strengthening exercises have the potential to enhance physical function, increase independence, and improve overall quality of life for thalassemic child and Closed Kinetic Chain (CKC) exercises are proven to be beneficial due to their ability to engage multiple muscle groups simultaneously, leading to improved muscle strength and balance. Therefore the aim of the study was to determine the effect of closed kinetic chain exercises via telerehabilitation on muscle strength, balance, fatigue, and haemoglobin levels in Beta Thalassemia Major children This study involved 32 children aged 8-15 years with Beta thalassemia major, divided into experimental group (n = 16) receiving CKC exercises via telerehabilitation for 30-40-minutes, twice a week for 8 weeks, the control group (n = 16) receiving education on importance of being physically activity. Outcome measures were assessed at baseline, 4th week and 8th week which included balance using Bruininks-Oseretsky Test of Motor Proficiency (BOT-2); muscle strength, measured via hand-held dynamometer; fatigue levels by (PQL-MFS); and haemoglobin levels via the spectrophotometric method The experimental group showed significant improvements in balance (p < 0.001), muscle strength (p < 0.001), and fatigue reduction (p < 0.005), but no significant changes were observed on haemoglobin levels. An 8-week CKC exercise program delivered via telerehabilitation significantly enhanced balance, muscle strength, and reduced fatigue in children with Beta Thalassemia Major, though it did not affect haemoglobin levels.

#5

Role of Serum Apelin and Carotid Artery Intima Thickness in Predicting Early Atherosclerotic Changes in Children With Beta-Thalassemia Major.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2026 Jan

This case-control study, which was performed at a tertiary care center in India, involved sixty children between the ages of 5 and 18 who were already being treated as case of beta thalassemia major. All participants underwent routine biochemical investigations encompassing complete hemogram, viral markers, LFT, KFT, serum ferritin as per treating unit protocol, and specific tests including a 12-hour fasting lipid profile, carotid artery intima thickness (CIMT), and serum apelin levels. Appropriate Statistical Analysis were performed and p value was calculated and set at < 0.05 for it to be statistically significant. The index study showed that children with beta thalassemia had significantly lower serum cholesterol, LDL and HDL levels when contrasted with age matched controls and were also found to have mean CIMT and serum apelin levels significantly higher with p value < 0.001. Children living with beta thalassemia major are more likely to develop early sub-clinical atherosclerosis, and measures of serum apelin level and carotid artery intima thickness can be used in addition to routine lab parameters to determine the early stages of atherosclerosis in these patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC923 artigos no totalmostrando 199

2026

Antioxidant Effects of CoQ10 in Transfusion-Dependent β-Thalassemia Major Patients: Implications for Ferroptosis-Related Pathways.

Journal of blood medicine
2026

Compound Heterozygous Hemoglobin E-Beta (HbE-β)-Thalassemia Presenting With Chipmunk or Rodent Facies, and a Severe Thalassemia Major Phenotype.

Cureus
2026

Clinical integration of red cell genotyping in children with β-thalassemia major: a prospective observational study.

Blood global hematology
2026

Association Between Iron Overload and Glucose Metabolism in Children and Youth with Transfusion-Dependent Beta Thalassemia: The Role of Chelation Therapy.

Mediterranean journal of hematology and infectious diseases
2026

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan.

Hemoglobin
2025

Clinico-epidemiological Profile of Transfusion-dependent Thalassemia Patients in a Tertiary Care Children's Hospital in Nepal: An Observational Study.

JNMA; journal of the Nepal Medical Association
2026

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report.

Journal of inflammation research
2026

Reproductive Endocrine Stability Despite Persistent Hypogonadism in Well-Chelated Adult Women with Transfusion-Dependent β-Thalassemia.

Journal of clinical medicine
2026

Vitamin B12 Deficiency Does Not Induce Homocysteine Increase in Transfusion-Dependent β-Thalassemia Major Patients Receiving Folic Acid Supplementation.

Hemoglobin
2026

When HbA1c looks "too high": two practical clarifications for endocrine screening in chelated β-thalassemia major.

Therapeutic advances in endocrinology and metabolism
2026

Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy.

Therapeutic advances in hematology
2026

Beta-Thalassemia Major Complicated by Streptococcal Toxic Shock Syndrome: A Rare Case of Survival and Successful Management.

Case reports in hematology
2026

Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan.

Scientific reports
2026

Red blood cell alloimmunization in transfusion-dependent β-thalassemia major patients in Eastern Iran.

Annals of hematology
2026

The impact of the expression signatures of LncRNAs HBBP1 and XIST on the diagnostic significance of patients with β-Thalassemia.

Annals of hematology
2025

A Case Report of HLA 5/10 Cord Blood Cell Engraftment in a Patient with Severe β Thalassemia after Haplo-Cord Stem Cell Transplantation.

Annals of clinical and laboratory science
2026

Alterations in Serum MAO Activity and Tau Levels in β-Thalassemia.

Hemoglobin
2025

UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients.

Pharmacogenomics
2026

Altered cerebral morphometry and individual-based morphological brain network in children with beta-thalassaemia major.

Neuroscience
2025

Functional Abnormalities of the Endocrine System in Beta-Thalassemia Major Patients: Insights From a Hospital-Based Observational Study.

Cureus
2026

First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1-5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major.

Cell biochemistry and biophysics
2026

Adult-Onset β-Thalassemia Major as Acquired Imprinting Disorder.

American journal of hematology
2026

Effect of Closed Kinetic Chain Exercise Via Telerehabilitation on Muscle Strength, Balance, Fatigue and Hemoglobin Levels in Beta Thalassemia Major Children: A Randomized Controlled Trial.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2026

Role of Serum Apelin and Carotid Artery Intima Thickness in Predicting Early Atherosclerotic Changes in Children With Beta-Thalassemia Major.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2025

The second reported case of a hemolytic transfusion reaction caused by anti-Sc2: a clinical diagnosis.

Immunohematology
2026

Ovarian function compromise in pediatric beta-thalassemia major: a consequence of iron overload-induced mitochondrial and fibrotic damage.

Human reproduction (Oxford, England)
2025

Nutritional deficiencies among adults with beta thalassemia major in Vietnam.

Public health nutrition
2025

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy.

Therapeutic advances in endocrinology and metabolism
2025

Fragmented QRS duration as a marker of cardiac and hepatic iron overload: across-sectional study.

Scientific reports
2025

Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major.

Scientific reports
2025

Effects of fluconazole and voriconazole on cyclosporine levels and toxicity in allogenic hematopoietic stem cell transplant recipients: A comprehensive analysis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2025

Frequency of Zinc Deficiency Among Thalassemia Major Patients: A Comparative Cross-Sectional Study.

Cureus
2025

A pilot study on the prevalence and patterns of haemoglobinopathies in Datia District, Madhya Pradesh, India.

Scientific reports
2025

Assessment of Adherence to Iron Chelation Therapy Among Thalassemia Patients in Palestine.

Anemia
2026

Cardiovascular magnetic resonance derived pulmonary capillary wedge pressure in beta-thalassemia major: Clinical correlates and association with cardiac complications.

International journal of cardiology
2025

Placenta Percreta in the Absence of a Previous Uterine Scar.

Cureus
2025

Assessment of β-Thalassemia Trait Occurrence in an Outpatient Sample from Southern Chile: A Retrospective Study.

Diagnostics (Basel, Switzerland)
2025

Genetic Analysis of a Patient with β-Thalassemia Major and Homozygous Hb Constant Spring in a Chinese Family.

Clinical laboratory
2025

B-Type Natriuretic Peptides Levels in Patients With Beta-Thalassemia Major and Correlations With Biomarkers: A Systematic Review and Meta-Analysis.

Health science reports
2025

Immune cell reconstitution after allogeneic hematopoietic stem cell transplantation in children with β-thalassemia major.

Translational pediatrics
2025

Complete molecular spectrum of β-globin gene mutations via direct sequencing identifies seven novel variants in β-thalassemia major.

PloS one
2025

A Case Series on Beta Thalassemia Major With Secondary Diabetes Mellitus Due to Iron Overload and Other Complications.

Cureus
2025

Genetically Confirmed Dual Hematologic Disorder: A Case of β-Thalassemia with Frameshift Mutation and Type 3 von Willebrand Disease in a Pediatric Patient.

Hemoglobin
2026

Excellent Outcome of 1-Day Nonmyeloablative Salvage Regimen for Pediatric Patients with Graft Failure following Haploidentical Hematopoietic Stem Cell Transplantation.

Transplantation and cellular therapy
2025

Low rate of red cell alloimmunization among multiply transfused beta-thalassemia major patients in the Wasit province of Iraq.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
2025

Evaluating Dried Blood Spot and Dried Blood Matrix as Alternatives to Venipuncture for Diagnosing Haemoglobinopathies in Adults: A Mass Spectrometric Approach.

Journal of mass spectrometry : JMS
2025

Glymphatic dysfunction as an imaging biomarker for cognitive impairment in patients with β-thalassemia major: A multimodal MRI study.

European journal of radiology open
2025

Chelation: The Double-Edged Sword. A Case Report of Invasive, Disseminated Mucor Mycosis in a Beta Thalassemia Major During Transplant.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2025

Evaluation of osteoporosis in adult patients with beta-thalassemia major and its relation to serum sclerostin level.

Clinics and research in hepatology and gastroenterology
2025

Iron Overload and Its Impact on Liver Function and Lipid Profiles in Transfusion-Dependent β-Thalassemia Patients in Sana'a City.

Journal of blood medicine
2025

Impact of SNP Variants in PON-1 or UGT1A1 on Iron Chelation Therapy Outcomes and Zinc Status in Thalassemia Major Patients.

Biological trace element research
2025

Effect of Therapy Reminder Application on Treatment Adherence in Adults with Beta-Thalassemia Major: A Randomized Clinical Trial.

Iranian journal of medical sciences
2026

Late renal, liver, endocrine, and cardiac outcomes of bone marrow transplantation in Kurdish children with β-thalassemia major.

International journal of hematology
2025

Assessment of natural killer cell subpopulations in pediatric patients with transfusion-dependent β-thalassemia major.

Clinical and experimental pediatrics
2025

Machine and deep learning for MRI-based quantification of liver iron overload: a systematic review and meta-analysis.

Radiologie (Heidelberg, Germany)
2025

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major.

Blood advances
2025

Challenges Associated with the Identification of Abnormal Hemoglobin Variants Utilizing the High-performance Liquid Chromatograph Technique: A Prospective Study in a Hospital Setting in Gujarat.

International journal of applied &amp; basic medical research
2025

Beta-Thalassemia Major With Iron Overload Cardiomyopathy and Refractory Cardiogenic Shock Requiring Mechanical Circulatory Support.

JACC. Case reports
2025

Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2026

Population-adjusted cut-off: A new approach for enhancing the diagnostic efficacy of hematological discrimination formulae for screening β-Thalassemia trait.

Clinica chimica acta; international journal of clinical chemistry
2025

Dietary Patterns Among Patients With Beta-Thalassemia Major in Vietnam.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association
2025

Assessment of health-related quality of life in transfusion dependent beta thalassemia.

Scientific reports
2025

Erythroid activity modulates iron regulation in pathological erythropoiesis: A cross-sectional case-control study.

The Indian journal of medical research
2025

Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.

Current medicinal chemistry
2025

Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world.

Clinical and experimental medicine
2025

Magnitude of Beta-Hemoglobinopathies through Biomarkers among the Selected Tribes of Dharmapuri, Tamil Nadu: A Community-Based Cross-Sectional Study.

International journal of hematology-oncology and stem cell research
2025

Unveiling success: determinants of a successful haematopoietic stem cell transplant: a case report.

JPMA. The Journal of the Pakistan Medical Association
2025

Evaluation of Immune Functions in Transfusion-Dependent Thalassemia Patients with Alloimmunization.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2025

Prevalence of Candida albicans in the oral cavity of Beta Thalassemia Major and Thalassemia Minor Patients.

F1000Research
2025

Leptin and thyroid hormones in beta-thalassemia major: A cross-sectional study.

Caspian journal of internal medicine
2025

The Association between β-Thalassemia Major (β-TM) and Cardiac Complications: Recent Insights.

Current cardiology reviews
2025

Association of healthy eating behaviours and comorbidity on quality of life among adults with beta-thalassemia major: a moderation analysis.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2025

Hyperhomocysteinemia in pediatric β-thalassemia: links to vitamin cofactor deficiencies and oxidative stress.

Clinical and experimental pediatrics
2025

Prediction model for cytomegalovirus infection following hematopoietic stem cell transplantation in patients with β-thalassemia major.

SAGE open medicine
2025

Risk-Stratified Pretransplant Immunosuppressive Strategy Improves Outcomes of Unrelated Cord Blood Transplantation in Pediatric β-Thalassemia Major.

Transplantation and cellular therapy
2025

Study of Thyroid Function in Children With Beta-Thalassemia Major.

Cureus
2025

Retinal Complications in a Patient With Pediatric Thalassemia: A Case Report.

Cureus
2025

Survey of Red Cell Transfusion Therapy and Immunohematology Services for Patients with Hemoglobinopathies in Türkiye.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2025

Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
2024

Vitamin D Deficiency among Blood Transfusion Dependent Beta Thalassemia Children Admitted to Tertiary Level Pediatric Hospital in Nepal: A Descriptive Cross-sectional Study.

JNMA; journal of the Nepal Medical Association
2025

Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation.

Therapeutic advances in hematology
2025

The direct costs of transfusion-dependent beta-thalassemia in Saudi Arabia: A cost of illness analysis study.

Medicine
2025

KLF1 Knockdown Differentially Regulates γ-Globin Expression: Inhibition in K562 Cells but Reactivation in β-Thalassemia Major Erythrocytes with Erythropoiesis Disruption.

Hemoglobin
2025

Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies.

Transplantation and cellular therapy
2025

Seroepidemiology of Toxoplasma gondii infection among patients with beta-thalassemia major: a case-control study in Southeastern Iran.

BMC infectious diseases
2025

Impacts of Hematopoietic Stem Cell Transplantation on Quality of Life and Behavioral Outcomes in Pediatric Patients with Leukemia and Thalassemia.

Current oncology (Toronto, Ont.)
2025

Optical coherence tomography findings in beta-thalassemia major: a systematic review and Meta-analysis.

International journal of ophthalmology
2025

Study on Large-Scale Brain Network Abnormalities in Patients With Beta-Thalassemia.

Brain and behavior
2025

Correlation between vitamin D level and left ventricular myocardial function demonstrated by speckle tracking echocardiography among β-thalassemia major children.

European journal of pediatrics
2025

Moyamoya syndrome in a 6-year-old β-thalassemia major patient: A case report.

Radiology case reports
2025

Clinical course and management of hypertriglyceridemia thalassemia syndrome: A case-based systematic review.

World journal of clinical pediatrics
2025

The role of iron in normal and impaired testicular function.

Andrology
2025

Liver Function Parameters and Validation of Health-Related Quality of Life Assessment of β-Thalassemia Cases at a Tertiary Care Hospital, Lumbini Province, Nepal.

Kathmandu University medical journal (KUMJ)
2025

Using Blood Group Genotyping to Predict Hemolysis in Patients With β-Thalassemia Major With Frequent Transfusions: Protocol for a Cross-Sectional Study.

JMIR research protocols
2025

Clinical Image-Vertebral artery beading in a child with Beta Thalassemia major.

Oxford medical case reports
2025

The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?

Pituitary
2025

Spectrum of Ophthalmic Manifestations in Patients With Transfusion-Dependent Thalassemia.

Cureus
2025

Prevalence and Significance of Pancreatic Iron in Transfusion-Dependent Sickle Cell Disease.

Pediatric blood &amp; cancer
2025

Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model.

Blood
2025

Clinical Profile and Vitamin D Status in Beta Thalassemia Major Children at a Tertiary Care Institute of Central India: A Cross-Sectional Study.

Nigerian journal of clinical practice
2025

Experiences of Iranian Patients with Thalassemia Major Regarding Their Palliative and Supportive Care Needs: A Qualitative Content Analysis.

International journal of community based nursing and midwifery
2025

FACTORS AFFECTING HEALTH RELATED QUALITY OF LIFE IN ADULT PATIENTS WITH BETA-THALASSEMIA MAJOR.

Georgian medical news
2025

The Possibilities and Importance of Assessing the Left Atrioventricular Coupling Index Using Various Diagnostic Imaging Methods in an Adult Population: A Comprehensive Review.

Journal of cardiovascular development and disease
2025

Awareness About Thalassemia Among the Parents of Thalassemic Children in Balochistan: A Cross-Sectional Study.

Health science reports
2025

Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised β-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13.

Annals of hematology
2025

Investigation of alloimmunization in beta-thalassemia major patients: a cross-sectional study.

Annals of medicine and surgery (2012)
2025

The effect of aqueous extract of Iranian oak (Quercus brantii) on lipid profile and liver enzymes in beta-thalassemia patients: a randomized controlled trial, double-blind, placebo-controlled.

Frontiers in nutrition
2025

How bad can vision get in beta-thalassemia? A case report and review of the literature.

BMC ophthalmology
2025

Controlled release of deferiprone using iron-responsive nanoparticles integrated with dissolving microneedle for novel alternative treatments of β-thalassemia major.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2025

A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report.

Journal of medical case reports
2025

Research on iron regulatory erythroid factors in children with β-thalassemia.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2025

Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism.

Diagnostics (Basel, Switzerland)
2025

Iron Overload-Related Oxidative Stress Leads to Hyperphosphorylation and Altered Anion Exchanger 1 (Band 3) Function in Erythrocytes from Subjects with β-Thalassemia Minor.

International journal of molecular sciences
2024

Correlation of Klotho Protein with Troponin-I as a Marker of Myocardial Damage in Iraqi Beta-Thalassemia Major Patients.

Reports of biochemistry &amp; molecular biology
2025

Pelvic extramedullary hematopoiesis with life-threatening hemorrhage: a case report.

International journal of emergency medicine
2025

Factors associated with phosphate homeostasis in children with beta-thalassemia major: An analytical cross sectional study from Pakistan.

PloS one
2025

Prevalence of Alloimmunization Events in Thalassemia Patients With Repeated Transfusions in the Rhesus Blood Group System: A Systematic Review and Meta Analysis.

Journal of clinical medicine research
2025

Effects of Thalidomide on Metabolism and Lifespan of Red Blood Cell in Patients With β-Thalassemia Major: A Post Hoc Analysis of a Randomized Controlled Trial.

Clinical therapeutics
2025

Lessons from Beta-Thalassemia for Improving Iron Overload Monitoring and Management in Kidney Failure.

Cureus
2025

Evaluation and Effect of Transfusion on Respiratory Functions in Patients with β-Thalassemia Major.

Pediatric allergy, immunology, and pulmonology
2025

Cardiac injury caused by iron overload in thalassemia.

Frontiers in pediatrics
2025

Systematic identification and validation of ceRNA-driven regulatory mechanisms in pediatric β-Thalassemia major.

Annals of hematology
2025

Left ventricular diastolic and systolic functions by cardiac magnetic resonance in beta-thalassemia major: correlation with clinical findings and cardiac complications.

The international journal of cardiovascular imaging
2025

Correlation study between magnetic resonance imaging-quantitated cardiac iron deposition and left ventricular function in patients with β-thalassemia major in China.

Science progress
2025

Assessment of cardiac iron deposition and genotypic classification in pediatric beta-thalassemia major: the role of cardiac MRI.

BMC medical imaging
2025

Family Planning practices among the parents of beta thalassemia major patients in Makran division, Balochistan: A cross-sectional study.

Pakistan journal of medical sciences
2025

Comparison of Asymptomatic Brain Lesions Between Thalassemia Major and Sickle Cell Anemia Patients.

Medicina (Kaunas, Lithuania)
2025

Beta-thalassemia major presenting as rachitic rosary in young adult.

BMJ case reports
2025

Pregnancy, delivery, and neonatal outcomes among women with beta-thalassemia major: a population-based study of a large US database.

Archives of gynecology and obstetrics
2024

Red blood cell alloimmunization among transfusion-dependent thalassemia major patients in Northeastern Iran.

Asian journal of transfusion science
2024

A scoping review on the obstacles faced by beta thalassemia major patients in Pakistan- Matter of policy investment.

AIMS public health
2024

Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications.

Metabolites
2024

Cardiovascular Effects of Splenomegaly and Splenectomy in Beta-Thalassemia Major.

Cureus
2024

Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β-thalassemia major.

World journal of otorhinolaryngology - head and neck surgery
2025

The role of miR-129-5p in regulating γ-globin expression and erythropoiesis in β-thalassemia.

Human molecular genetics
2024

The growth and development of children with β-thalassemia major one year after allogeneic hematopoietic stem cell transplantation.

Translational pediatrics
2025

Iron-responsive nanoparticle-loaded bilayer dissolving microneedles for selective and controlled transdermal delivery of deferasirox in β-thalassemia major treatment.

Colloids and surfaces. B, Biointerfaces
2024

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles.

Frontiers in pharmacology
2024

Shear Wave Elastography in the Assessment of Liver Iron Overload in Children With Beta Thalassemia Major.

Ultrasound quarterly
2024

Serum lipid profile abnormalities among beta-thalassemia patients: a systematic review and meta-analysis.

Lipids in health and disease
2024

COMPARISON OF DIFFERENT TREATMENT MODALITIES OF CHELATION THERAPY IN BETA-THALASSEMIA MAJOR PATIENTS.

Journal of Ayub Medical College, Abbottabad : JAMC
2025

Gut microbiota-derived TMAO and SIRT1/HMGB1 Axis: unveiling mechanisms of renal impairment in beta-thalassemia major.

Pediatric research
2024

Effects of Thalidomide on Endothelial Activation and Stress Index in Children with β-Thalassemia Major.

Mediterranean journal of hematology and infectious diseases
2024

Assessment of diagnostic accuracy of Gazelle: A point-of-care testing device for screening β-thalassemia trait.

The Indian journal of medical research
2024

Cardiovascular magnetic resonance in β-thalassemia major: beyond T2.

La Radiologia medica
2024

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics.

Frontiers in pharmacology
2024

Existing Tubular Injury in β-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia.

Hemoglobin
2024

Health-Related Quality of Life of Adolescents With Non-transfusion-Dependent Thalassemia in Basrah, Iraq.

Cureus
2024

Genetic Study for Identifying Beta Thalassemia Trait in Relatives of Children with Beta Thalassemia Major.

Cureus
2024

A Rare Case of Pulmonary Neuroendocrine Carcinoma in Transfusion-dependent Thalassemia Patient: Clinical Presentation, Management, and Implications.

Acta medica Indonesiana
2024

Impact of met-haemoglobin and oxidative stress on endothelial function in patients with transfusion dependent β-thalassemia.

Scientific reports
2025

Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia.

Molecular medicine reports
2024

Gene Therapy: A Revolutionary Step in Treating Thalassemia.

Hematology reports
2025

The gut microbiota metabolite trimethylamine-N-oxide in children with β-thalassemia: potential implication for iron-induced renal tubular dysfunction.

Pediatric research
2024

EVALUATION OF PROTEIN C AND S IN Β-THALASSEMIA MAJOR.

Georgian medical news
2024

Impact of Empagliflozin on the Outcomes of β-Thalassemia Major in Patients With Type 2 Diabetes Mellitus: The THALEMPA Observational Study.

Cureus
2024

β-Thalassemia Major Complicated by Acute Myeloid Leukemia.

Cureus
2024

Iron overload and liver function in patients with beta thalassemia major: A cross sectional study.

Pakistan journal of medical sciences
2024

Bone Mineral Density, Osteoporosis Prevalence and Influential Factors in Osteogenesis in Patients with Beta Thalassemia Major: A Cross-Sectional Study.

Iranian journal of public health
2024

Knowledge, attitude and acceptance regarding bone marrow transplantation in caregivers of beta-thalassemia major patients.

Journal of community genetics
2024

Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patterns.

Proceedings of the National Academy of Sciences of the United States of America
2024

An Unexpected Detection of the Rare 48,XXYY in the Prenatal Diagnosis of a Fetus with β-Thalassemia Major.

Clinical laboratory
2024

Antioxidative effects of N-acetylcysteine in patients with β-thalassemia: A quick review on clinical trials.

Health science reports
2024

Early detection of myocardial iron overload in patients with β-thalassemia major using cardiac magnetic resonance T1 mapping.

Magnetic resonance imaging
2024

A rare glimpse of Fessas bodies in a patient with β-thalassemia major postsplenectomy.

Blood
2024

The effect of applying emotional intelligence components on coping strategies in adolescents with beta-thalassemia major: a randomized clinical trial.

BMC pediatrics
2024

Effectiveness of topical 25% silver nitrate solution followed by 5% fluoride varnish compared to 38% silver diamine fluoride in arresting and preventing dental caries among beta-thalassemia major patients: A randomized clinical trial.

Journal of dentistry
2024

Acute and Chronic Effects of Interval Aerobic Exercise on Hepcidin, Ferritin, and Liver Enzymes in Adolescents With Beta-Thalassemia Major.

Pediatric exercise science
2024

Evaluation of myocardial strain using cardiovascular magnetic resonance imaging in patients with β-thalassemia major.

Journal of cardiovascular imaging
2024

Assessment of Serum Vitamin D and Parathyroid Hormone in Children With Beta Thalassemia Major: A Case-Control Study.

Cureus
2023

Comparison of oral iron chelators in the management of transfusion-dependent β-thalassemia major based on serum ferritin and liver enzymes.

F1000Research
2024

Red Cell Pyruvate Kinase Deficiency With Hypertriglyceridemia: A Case Report.

Cureus
2024

An Investigation of Group-Based Mobile Learning on Stress, Anxiety, Depression, and Pain Among Beta-Thalassemia Major Patients: A Randomized Control Trial.

Turkish archives of pediatrics
2024

Correlation of Electrocardiographic and Echocardiographic Changes with Serum Ferritin Level in Multi-Transfused β-Thalassemia Major Patients.

Indian journal of pediatrics
2024

Beta-Thalassemia Major and Myocardial Iron Overload: A Longitudinal Study with Magnetic Resonance Imaging.

Cardiology research and practice
2024

Global and regional cardiac magnetic resonance feature tracking left ventricular strain analysis in assessing early myocardial disease in β thalassemia major patients.

Journal of cardiovascular imaging
2024

Soluble Fms-like tyrosine kinase-1 as an endothelial dysfunction biomarker associated with pulmonary hypertension in adult patients with beta-thalassemia major.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2024

Multidisciplinary Management of Oral Manifestations in Pregnant Women with Beta-Thalassemia Major: A Case Report.

International medical case reports journal
2024

Association of serum ferritin trends with liver enzyme patterns in β-thalassemia major: A longitudinal correlational study.

Journal of family medicine and primary care
2024

Assessing Psychological Disorders in Turkish Adolescents with Transfusion-Dependent Thalassemia.

Children (Basel, Switzerland)
2024

Manuka combinations with nigella sativa and hydroxyurea in treating iron overload of pediatric β-thalassemia major, randomized clinical trial.

Heliyon
2024

Serum visfatin level in β-thalassemia and its correlation with disease severity.

Journal of medicine and life
2025

Neuroimaging in the diagnosis and treatment of cerebral toxoplasmosis in children with severe β-thalassemia after allo-HSCT.

Biomolecules &amp; biomedicine
2024

The effect of blood transfusion on serum hepcidin levels in chronically transfused patients of β-thalassemia major: An observational study in a tertiary care centre in Western Maharashtra.

Asian journal of transfusion science
2024

Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient.

Asian journal of transfusion science
2024

Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study.

Pediatric hematology and oncology
2024

Health-related Quality of Life of Omani Adult Patients with β-Thalassemia Major at Sultan Qaboos University Hospital.

Oman medical journal
2024

Global longitudinal strain by cardiac magnetic resonance is associated with cardiac iron and complications in beta-thalassemia major patients.

International journal of cardiology
2024

Cross-sectional study on the impact of cardiac and hepatic iron overload, as measured by MRI T2*, on the quality of life in children with severe beta-thalassemia major.

Medicine
2025

Genetic Correlation of HBB, HFE and HAMP Genes to Endocrinal Complications in Egyptian Beta Thalassemia Major Patients.

Biochemical genetics
2024

Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital.

Journal of family medicine and primary care
2024

Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study.

Iranian journal of immunology : IJI
2024

Exploring the Clinical and Hematological Characteristics of Beta-Thalassemia Trait: A Comprehensive Analysis in a Tertiary Care Hospital Setting.

Cureus
2024

How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.

Iranian journal of public health
2024

Beta-Thalassemia in Adulthood Previously Suspected as Treatment-Resistant Iron Deficiency Anemia: A Case Report.

Cureus
2024

Capnocytophaga canimorsus Meningitis Complicated by Septic Shock: The Use of Extracorporeal Blood Purification Techniques.

Cureus
2024

HHV6-Associated Hydrocephalus in a Pediatric Hematopoietic Stem Cell Transplant Recipient: An Unusual Presentation.

Journal of pediatric hematology/oncology
2024

Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients.

Journal of clinical laboratory analysis
2024

COMPARATIVE STUDY OF OXIDATIVE STRESS IN PATIENTS WITH Β -THALASSEMIA MAJOR ON DEFERASIROX VERSUS DEFEROXAMINE THERAPY.

Georgian medical news
Ver todos os 923 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Talassemia beta major.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Talassemia beta major

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Antioxidant Effects of CoQ10 in Transfusion-Dependent &#x3b2;-Thalassemia Major Patients: Implications for Ferroptosis-Related Pathways.
    Journal of blood medicine· 2026· PMID 41878153mais citado
  2. Clinical integration of red cell genotyping in children with &#x3b2;-thalassemia major: a prospective observational study.
    Blood global hematology· 2026· PMID 41852790mais citado
  3. Altered cerebral morphometry and individual-based morphological brain network in children with beta-thalassaemia major.
    Neuroscience· 2026· PMID 41619874mais citado
  4. Effect of Closed Kinetic Chain Exercise Via Telerehabilitation on Muscle Strength, Balance, Fatigue and Hemoglobin Levels in Beta Thalassemia Major Children: A Randomized Controlled Trial.
    Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion· 2026· PMID 41522555mais citado
  5. Role of Serum Apelin and Carotid Artery Intima Thickness in Predicting Early Atherosclerotic Changes in Children With Beta-Thalassemia Major.
    Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion· 2026· PMID 41522554mais citado
  6. Non-invasive prenatal diagnosis of beta-thalassemia disease using digital PCR.
    Front Med (Lausanne)· 2026· PMID 41982550recente
  7. Reduced number of endothelial progenitor cells in adult patients with beta thalassemia major.
    Ann Hematol· 2026· PMID 41979693recente
  8. "Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation" - A Cross-Sectional Comparative Study.
    Hemoglobin· 2026· PMID 41943944recente
  9. Comparative Study of Ferritin Levels between Two Generic Formulations of Deferasirox in Sri Lankan Patients with Beta-Thalassemia Major.
    Hemoglobin· 2026· PMID 41943525recente
  10. Assessment of Serum Ferritin, Thyroid Profile and Calcium Homeostasis in Beta-Thalassemia Major Patients.
    Cureus· 2026· PMID 41939687recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:231214(Orphanet)
  2. MONDO:0016486(MONDO)
  3. Talassemia(PCDT · Ministério da Saúde)
  4. GARD:17162(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q56013833(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Talassemia beta major
Compêndio · Raras BR

Talassemia beta major

ORPHA:231214 · MONDO:0016486
🇧🇷 Brasil SUS
CEAF
1AMitapivate
Geral
Prevalência
Unknown
Herança
Autosomal recessive
CID-10
D56.1 · Talassemia beta
CID-11
Ensaios
31 ativos
Medicamentos
5 registrados
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0002875
Repurposing
2 candidatos
deferasiroxchelating agent
deferiprone
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades